Bispec 5 mg Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Bispec 5 mg Tablet is a muscarinic antagonist (antimuscarinic) medicine. Its labelling describes it for the treatment of an overactive bladder, helping reduce urinary symptoms such as frequent urination and the inability to control urination. It is described as working by helping the muscles of the urinary bladder relax, which prevents frequent, urgent, or uncontrolled urination. The doctor decides the dose and how often it is taken, and it is administered orally as advised.

Active ingredient
Antimuscarinic agent — confirmed per enquiry
Strength
5 mg
Dosage form
Oral tablet
Therapeutic class
Muscarinic antagonist (for overactive bladder)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of overactive bladder syndrome (OAB)
  • Described as reducing urinary symptoms such as frequent urination and inability to control urination
  • Described as relaxing the urinary bladder muscles to prevent frequent, urgent, or uncontrolled urination
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken only if advised by a doctor; not to be used if not prescribed
  • The doctor decides the dose and how often it is taken
  • Administered orally as advised by the doctor

Described Side Effects

Commonly described side effects include:

  • Upset stomach
  • Constipation
  • Dryness in the mouth
  • Blurred vision
  • Nausea
  • Urinary tract infection

Most of these are described as not persisting for long and as disappearing after some time; a doctor should be consulted if they last longer.

Precautions

  • Described as possibly unsafe for pregnant mothers — a doctor should be consulted before use
  • Described as possibly safe for breastfeeding mothers, though a doctor’s advice should be obtained
  • Patients with kidney or liver problems are advised to use it with caution
  • Described as not advised for patients with severe kidney and liver problems

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it is a muscarinic antagonist used for the treatment of overactive bladder syndrome, reducing urgency, frequency, and inability to control urination. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as taken orally as advised by the doctor, who decides the dose and how often it is taken.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services